ClinicalTrials HQ

Oxford Pre-cancerous Lymphoproliferative Disorders Study

Oxford Pre-cancerous Lymphoproliferative Disorders Study

Active, not recruiting · NCT04023747 · Registry updated 2025-02-03
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Oxford Pre-cancerous Lymphoproliferative Disorders StudyBlood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, hematologic disorder, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, precancerous condition, smoldering plasma cell myelomaActive, not recruitingNot stated2025-02-03NCT04023747

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Janssen Research & Development, LLC188
University of Oxford213

17 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Churchill Hospital, Oxford University Hospitals TrustOxfordUnited Kingdom1
Clatterbridge Cancer CentreLiverpoolUnited Kingdom5
Derriford HospitalPlymouthUnited Kingdom27
Epsom HospitalLondonUnited Kingdom1
James Paget HospitalGreat YarmouthUnited Kingdom1
King's College HospitalLondonUnited Kingdom45
Leicester Royal InfirmaryLeicesterUnited Kingdom19
Musgrove Park HospitalTauntonUnited Kingdom7
North Tyneside General HospitalNorth ShieldsUnited Kingdom3
Northern Centre for Cancer CareNewcastleUnited Kingdom1
Poole HospitalPooleUnited Kingdom2
Queens Medical CentreNottinghamUnited Kingdom5
Royal Bournemouth HospitalBournemouthUnited Kingdom16
Russells Hall HospitalDudleyUnited Kingdom4
South Tyneside District HospitalSouth ShieldsUnited Kingdom1
St George's HospitalLondonUnited Kingdom6
Sunderland Royal HospitalSunderlandUnited Kingdom6